<?xml version="1.0" encoding="UTF-8"?>
<document>
<type>mainstream</type>
<forum>http://feeds2.feedburner.com/AmericanBankingNews</forum>
<forum_title>American Banking News</forum_title>
<discussion_title>athenahealth, Inc (ATHN) Receives “Buy” Rating from Oppenheimer</discussion_title>
<language>english</language>
<gmt_offset></gmt_offset>
<topic_url>http://www.americanbankingnews.com/2016/04/25/athenahealth-inc-athn-receives-buy-rating-from-oppenheimer/</topic_url>
<topic_text>
Tweet 
athenahealth, Inc (NASDAQ:ATHN) ‘s stock had its “buy” rating restated by Oppenheimer in a research note issued on Monday, MarketBeat reports. 
Shares of athenahealth ( NASDAQ:ATHN ) traded up 2.43% during trading on Monday, hitting $141.67. The company had a trading volume of 292,537 shares. The stock has a market capitalization of $5.52 billion and a P/E ratio of 404.77. athenahealth has a 52 week low of $110.68 and a 52 week high of $170.42. The firm’s 50 day moving average is $135.99 and its 200-day moving average is $145.20. 
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, February 4th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.04. The business earned $257.50 million during the quarter, compared to analyst estimates of $257.68 million. The company’s revenue was up 20.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.58 earnings per share. Equities research analysts anticipate that athenahealth will post $1.75 EPS for the current fiscal year. 
In other news, EVP Kristi Ann Matus sold 415 shares of the business’s stock in a transaction that occurred on Monday, February 1st. The shares were sold at an average price of $141.08, for a total transaction of $58,548.20. Following the sale, the executive vice president now owns 33,772 shares in the company, valued at $4,764,553.76. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink . Also, CMO Timothy John O’brien sold 816 shares of the business’s stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $127.08, for a total transaction of $103,697.28. Following the sale, the chief marketing officer now owns 1,250 shares in the company, valued at approximately $158,850. The disclosure for this sale can be found here . 
Several large investors have recently added to or reduced their stakes in the stock. Reynolds Capital Management purchased a new stake in athenahealth during the fourth quarter worth about $338,000. Great West Life Assurance Co. Can raised its position in athenahealth by 24.5% in the fourth quarter. Great West Life Assurance Co. Can now owns 4,358 shares of the company’s stock valued at $702,000 after buying an additional 858 shares in the last quarter. CrestPoint Capital Management LLC bought a new position in athenahealth during the first quarter valued at $971,000. Simplex Trading raised its position in athenahealth by 261.3% in the fourth quarter. Simplex Trading now owns 6,500 shares of the company’s stock valued at $1,046,000 after buying an additional 4,701 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in athenahealth by 79.9% in the fourth quarter. Principal Financial Group Inc. now owns 6,523 shares of the company’s stock valued at $1,050,000 after buying an additional 2,897 shares in the last quarter. 
A number of other research firms have also recently commented on ATHN. Canaccord Genuity reiterated a “hold” rating and issued a $140.00 price objective on shares of athenahealth in a report on Friday, January 22nd. Cowen and Company reiterated an “outperform” rating and issued a $162.00 price objective (down from $174.00) on shares of athenahealth in a report on Friday, February 5th. FBR &amp; Co. reiterated a “hold” rating and issued a $135.00 price objective on shares of athenahealth in a report on Friday, February 5th. Deutsche Bank reiterated a “buy” rating on shares of athenahealth in a report on Tuesday, April 5th. Finally, Zacks Investment Research upgraded athenahealth from a “hold” rating to a “strong-buy” rating and set a $159.00 price objective on the stock in a report on Monday. Four analysts have rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $150.95. 
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records ( NASDAQ:ATHN ), patient engagement, care coordination, population health management, as well as clinical intelligence and decision support.  //www.americanbankingnews.com/2016/04/25/athenahealth-inc-athn-receives-buy-rating-from-oppenheimer/   athenahealth Inc   athenahealth Inc  
</topic_text>
<spam_score>0.00</spam_score>
<post_num>1</post_num>
<post_id>post-1</post_id>
<post_url>http://www.americanbankingnews.com/2016/04/25/athenahealth-inc-athn-receives-buy-rating-from-oppenheimer/</post_url>
<post_date>20160425</post_date>
<post_time>1839</post_time>
<username>ABMN Staff</username>
<post>
Tweet 
athenahealth, Inc (NASDAQ:ATHN) ‘s stock had its “buy” rating restated by Oppenheimer in a research note issued on Monday, MarketBeat reports. 
Shares of athenahealth ( NASDAQ:ATHN ) traded up 2.43% during trading on Monday, hitting $141.67. The company had a trading volume of 292,537 shares. The stock has a market capitalization of $5.52 billion and a P/E ratio of 404.77. athenahealth has a 52 week low of $110.68 and a 52 week high of $170.42. The firm’s 50 day moving average is $135.99 and its 200-day moving average is $145.20. 
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, February 4th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.04. The business earned $257.50 million during the quarter, compared to analyst estimates of $257.68 million. The company’s revenue was up 20.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.58 earnings per share. Equities research analysts anticipate that athenahealth will post $1.75 EPS for the current fiscal year. 
In other news, EVP Kristi Ann Matus sold 415 shares of the business’s stock in a transaction that occurred on Monday, February 1st. The shares were sold at an average price of $141.08, for a total transaction of $58,548.20. Following the sale, the executive vice president now owns 33,772 shares in the company, valued at $4,764,553.76. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink . Also, CMO Timothy John O’brien sold 816 shares of the business’s stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $127.08, for a total transaction of $103,697.28. Following the sale, the chief marketing officer now owns 1,250 shares in the company, valued at approximately $158,850. The disclosure for this sale can be found here . 
Several large investors have recently added to or reduced their stakes in the stock. Reynolds Capital Management purchased a new stake in athenahealth during the fourth quarter worth about $338,000. Great West Life Assurance Co. Can raised its position in athenahealth by 24.5% in the fourth quarter. Great West Life Assurance Co. Can now owns 4,358 shares of the company’s stock valued at $702,000 after buying an additional 858 shares in the last quarter. CrestPoint Capital Management LLC bought a new position in athenahealth during the first quarter valued at $971,000. Simplex Trading raised its position in athenahealth by 261.3% in the fourth quarter. Simplex Trading now owns 6,500 shares of the company’s stock valued at $1,046,000 after buying an additional 4,701 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in athenahealth by 79.9% in the fourth quarter. Principal Financial Group Inc. now owns 6,523 shares of the company’s stock valued at $1,050,000 after buying an additional 2,897 shares in the last quarter. 
A number of other research firms have also recently commented on ATHN. Canaccord Genuity reiterated a “hold” rating and issued a $140.00 price objective on shares of athenahealth in a report on Friday, January 22nd. Cowen and Company reiterated an “outperform” rating and issued a $162.00 price objective (down from $174.00) on shares of athenahealth in a report on Friday, February 5th. FBR &amp; Co. reiterated a “hold” rating and issued a $135.00 price objective on shares of athenahealth in a report on Friday, February 5th. Deutsche Bank reiterated a “buy” rating on shares of athenahealth in a report on Tuesday, April 5th. Finally, Zacks Investment Research upgraded athenahealth from a “hold” rating to a “strong-buy” rating and set a $159.00 price objective on the stock in a report on Monday. Four analysts have rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $150.95. 
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records ( NASDAQ:ATHN ), patient engagement, care coordination, population health management, as well as clinical intelligence and decision support.  //www.americanbankingnews.com/2016/04/25/athenahealth-inc-athn-receives-buy-rating-from-oppenheimer/   athenahealth Inc   athenahealth Inc  
</post>
<signature>

</signature>
<external_links>

</external_links>
<country>US</country>
<main_image>http://www.americanbankingnews.com/logos/athn-logo.JPG</main_image>
</document>
